TrialThe oncologist2024

Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer.

Wasat Mansoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.